$LUCD
Lucid Diagnostics Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$0.510
▲+53.03%+$0.177
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLucid Diagnostics Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is LUCD up today? It is at $0.510 (+53.03%), and our scanner flagged it 85 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LUCD spikes, and full due diligence on LUCD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LUCD 85 times in the last 30 days. Create a free account to track $LUCD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
LUCD is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on LUCD today, peaking at 618.0x its normal volume. Fresh from the SEC: Lucid Diagnostics Inc. filed an 8-K: Unregistered Share Sale, Shareholder Rights Change, Charter / Bylaw Change. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystUnregistered Share Sale · Charter / Bylaw Change, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 40% of the tradeable float is in play - 40% more can still be issued.
Some filings did not state a size, so these are floors.
Shelf sizes are dollars, so shares are estimated at today's price.
Recent share offering + active shelf on file — the company raised capital and can raise more
About $175.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Matheis Dennis Director | Bought (open market) | +245K 0.1% of company | added 31% | 1.03M | $245K at $1.00 | May 20, 26 |
Gordon Michael Adam Officer | Acquired (grant/award) | +300K 0.1% of company | added 43% | 1.00M | n/a | Feb 20, 26 |
O'Neil Shaun Officer | Acquired (grant/award) | +620K 0.3% of company | added 75% | 1.45M | n/a | Feb 20, 26 |
Mcgrath Dennis M Officer | Acquired (grant/award) | +470K 0.2% of company | added 35% | 1.81M | n/a | Feb 20, 26 |
Cox James L Director | Acquired (grant/award) | +123K 0.06% of company | added 44% | 405K | n/a | Feb 20, 26 |
Lapidus Stanley Director | Acquired (grant/award) | +123K 0.06% of company | added 57% | 337K | n/a | Feb 20, 26 |
Palumbo John R Director | Acquired (grant/award) | +123K 0.06% of company | added 57% | 338K | n/a | Feb 20, 26 |
Sokolov Jacque J Director | Acquired (grant/award) | +123K 0.06% of company | added 62% | 320K | n/a | Feb 20, 26 |
Sparks Ronald M Director | Acquired (grant/award) | +123K 0.06% of company | added 62% | 320K | n/a | Feb 20, 26 |
White Debra Director | Acquired (grant/award) | +123K 0.06% of company | added 100% | 236K | n/a | Feb 20, 26 |
Matheis Dennis Director | Acquired (grant/award) | +123K 0.06% of company | added 18% | 788K | n/a | Feb 20, 26 |
Aklog Lishan Officer | Acquired (grant/award) | +2.17M 1.1% of company | added 100% | 3.64M | n/a | Feb 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
LUCD is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on LUCD today, peaking at 618.0x its normal volume. Fresh from the SEC: Lucid Diagnostics Inc. filed an 8-K: Unregistered Share Sale, Shareholder Rights Change, Charter / Bylaw Change. A material company disclosure like this is often the real catalyst behind a move of this size.
LUCD last traded at $0.510, up 53.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lucid Diagnostics Inc. Common Stock (LUCD) is next expected to report earnings on Wednesday, November 11, 2026, about 20 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LUCD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LUCD 85 times in the last 30 days.
LUCD (Lucid Diagnostics Inc. Common Stock) trades on XNAS, with a market cap of about $68M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LUCD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LUCD discussion
Sign in to ask a question or join the discussion.